TY - JOUR
T1 - Inflammation and thrombosis in cardiovascular disease
AU - Nagareddy, Prabhakara
AU - Smyth, Susan S.
PY - 2013/9
Y1 - 2013/9
N2 - PURPOSE OF REVIEW: This article will summarize recent observations that provide mechanistic insight into the molecular and cellular links between inflammation and thrombosis in the context of cardiovascular and other thromboinflammatory disease states. RECENT FINDINGS: Several disease conditions are characterized by a thromboinflammatory state in which interactions of blood cells and components with the vascular wall perpetuate both thrombotic and inflammatory pathways. Targeting these pathways may be of benefit in inflammatory conditions and cardiovascular disease. SUMMARY: Ongoing clinical trials should provide additional insight into the hypothesis that the thromboinflammatory state contributes to adverse clinical outcomes.
AB - PURPOSE OF REVIEW: This article will summarize recent observations that provide mechanistic insight into the molecular and cellular links between inflammation and thrombosis in the context of cardiovascular and other thromboinflammatory disease states. RECENT FINDINGS: Several disease conditions are characterized by a thromboinflammatory state in which interactions of blood cells and components with the vascular wall perpetuate both thrombotic and inflammatory pathways. Targeting these pathways may be of benefit in inflammatory conditions and cardiovascular disease. SUMMARY: Ongoing clinical trials should provide additional insight into the hypothesis that the thromboinflammatory state contributes to adverse clinical outcomes.
KW - cardiovascular disease
KW - inflammation
KW - thrombosis
UR - http://www.scopus.com/inward/record.url?scp=84883263674&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883263674&partnerID=8YFLogxK
U2 - 10.1097/MOH.0b013e328364219d
DO - 10.1097/MOH.0b013e328364219d
M3 - Review article
C2 - 23892572
AN - SCOPUS:84883263674
SN - 1065-6251
VL - 20
SP - 457
EP - 463
JO - Current Opinion in Hematology
JF - Current Opinion in Hematology
IS - 5
ER -